Financial Enhancement Group LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 287 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Financial Enhancement Group LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$22,000
+83.3%
1000.0%0.00%
+33.3%
Q4 2020$12,000
+20.0%
1000.0%0.00%
+50.0%
Q3 2020$10,000
-16.7%
1000.0%0.00%
-33.3%
Q2 2020$12,000
+33.3%
1000.0%0.00%0.0%
Q1 2020$9,000
-10.0%
1000.0%0.00%0.0%
Q4 2019$10,0001000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders